A MISC 04981 CLS 2022 1313x437 1

What is Chicago Lymphoma Symposium?

The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be offered hybrid with in-person and virtual components on Friday and Saturday and will include a combination of expert presentations, an interprofessional session including presentations on palliative care, psychosocial support and survivorship, , mini symposia Follicular Lymphoma, Mantle Cell Lymphoma,Hodgkin Lymphoma,Primary and Secondary CNS Lymphoma,Aggressive Lymphoma,and Next Generation Cellular and Targeted Therapies,Additionally, we’ll have a keynote presentation on Chronic Lymphocytic Leukemia.

Virtual symposium components will include:
  • LIVE stream session broadcast in real time
  • Opportunities to submit questions to presenters during the live broadcast
  • Ability to interact with other virtual participants via symposium attendee chat tool
  • Access to the virtual exhibit hall for connectivity and information
  • CME and MOC credits for physicians and CNE credits for nurses
  • Access to download presenter slide decks approved for release


Sonali M. Smith, MD

Elwood V. Jensen Professor of Medicine; Interim Chief, Section of Hematology/ Oncology; Director, Lymphoma Program,
The University of Chicago,
Chicago, Illinois

Andrew Evens, DO, MSc, FACP

Associate Director for Clinical Services, Rutgers Cancer Institute; System Director of Medical Oncology and Oncology Lead for Combined Medical Group, RWJBarnabas Health

Timothy Fenske, MD, MS

Professor, Division of Hematology and Oncology, Medical College of Wisconsin
Milwaukee, Wisconsin

Subscribe for Updates